• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Egalet a s - Product Pipeline Review - Q4 2010 - Product Image

Egalet a s - Product Pipeline Review - Q4 2010

  • ID: 1446898
  • November 2010
  • 25 pages
  • Global Markets Direct

Egalet a s – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Egalet a/s - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Egalet a/s - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Egalet a/s human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product READ MORE >



List of Tables
List of Figures
Egalet a/s Snapshot
Egalet a/s Overview
Key Information
Key Facts
Egalet a/s – Research and Development Overview
Key Therapeutic Areas
Egalet a/s – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Egalet a/s – Pipeline Products Glance
Egalet a/s Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Egalet a/s–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Egalet a/s – Drug Profiles
EG-P066
Product Description
Mechanism of Action
R&D Progress
EG-P113
Product Description
Mechanism of Action
R&D Progress
EG-P114
Product Description
Mechanism of Action
R&D Progress
EG-P118
Product Description
Mechanism of Action
R&D Progress
EG-P119
Product Description
Mechanism of Action
R&D Progress
EG-P121 Hydrocodone IR
Product Description
Mechanism of Action
R&D Progress
Egalet a/s – Pipeline Analysis
Egalet a/s – Pipeline Products by Therapeutic Class
Egalet a/s Pipeline Products By Target
Egalet a/s – Pipeline Products by Route of Administration
Egalet a/s – Pipeline Products by Molecule Type
Egalet a/s – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Note: Product cover images may vary from those shown

RELATED PRODUCTS